Skip to main content
HearingHELD · 4H 9MOPEN TO THE PUBLICOPENHOUSE · ENERGY AND COMMERCE › HEALTH ·

Prescription drug supply chain and costs

The Health Subcommittee examines how the prescription drug supply chain affects health care costs for Americans.

Wed, Feb 11 · 10:15 AM – 2:10 PM ETRayburn House Office Building, Room 2123Rayburn 2123

CHAIRH. Morgan Griffith R-VA-9
Diana DeGette D-CO-1
+ Calendar

Get a note when the testimony and answers to written questions are posted.

HOURS
4:09
WITNESSES
9
MEMBERS
32
STORIES
0

Watch

OFFICIAL COMMITTEE VIDEO · 4:09:05
Pick a point on the bar to jump thereTap the bar to jump4:09:05

Why this hearing

On the record: 9 witnesses: 8 from business and trade groups and 1 academic.

Witnesses include leaders of groups representing generic and brand-name drugmakers, biotechnology firms, pharmacy benefit managers, distributors and community pharmacists, along with a law professor and an employee-benefit group leader.

Real oversight or theater?

Did this hearing get real answers, or was it mostly speeches?

NO RATINGS YET

What each witness said

We haven’t summarized the witnesses’ statements yet.

Who asked what

We haven’t logged who asked questions at this hearing yet.

Question logs come from the committee’s official video.

The subcommittee

32 members · 18 Republicans, 14 Democrats

Witnesses

  • John MurphyPresident and CEO, Association for Accessible MedicinesFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • Rachel E. SachsProfessor of Law, Washington University in St. LouisFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • Lori Reilly, Esq.Chief Operating Officer, PhRMAFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • John CrowleyPresident and CEO, Biotechnology Innovation OrganizationFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • David MarinPresident and CEO, Pharmaceutical Care Management AssociationFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • Angie BoliverPresident and CEO, Healthcare Supply Chain AssociationFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • Chester “Chip” Davis, Jr.President and CEO, Healthcare Distribution AllianceFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • James GelfandPresident and CEO, The ERISA Industry CommitteeFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED
  • B. Douglas HoeyChief Executive Officer, National Community Pharmacists AssociationFirst appearance
    THIS CONGRESSFirst appearance
    NO STATEMENT POSTED

In the news

No news coverage of this hearing yet.

Timeline & documents

  1. Hearing noticed (done)
  2. Held (done)FEB 11 · 10:15 AM – 2:10 PM
  3. Video posted (done)FEB 11 · 2:10 PM
  4. Written testimony posted (not yet)NOT POSTED YET
  5. Questions for the record (not yet)NOT POSTED YET
  6. Printed transcript (not yet)USUALLY ABOUT 5 MONTHS AFTER THE HEARING
  • Written testimonyPENDING
  • Questions for the recordPENDING
  • Printed transcriptPENDING

aren’t posted yet. The printed transcript usually comes out about 5 months after the hearing (of hearings printed so far).

Related hearings

Data: Congress.gov committee meetings · House Committee Repository (docs.house.gov) · committee video on YouTube · GovInfo printed hearings · ChamberLight news coverage